CDT Equity Inc. Share Price

CDT Equity Inc. Share Price

NASDAQ: CDT | Micro Cap
$0.07
-$0.01 (-8.21%) Last updated on 30 Oct, 2026 | 21:26 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

CDT Equity Inc. Stock Performance

Open
$0.07
Prev. Close
$0.07
Circuit Range
N/A
Day Range
$0.07 - $0.07
Year Range
$0.07 - $9.81
Volume
4,700
Average Traded
$0.07

CDT Equity Inc. Share Price Today

As of 30 October 2026, CDT Equity Inc.'s share price is $0.07. The stock opened at $0.07, compared to its previous close of $0.07. During today's trading session, CDT Equity Inc.'s share price traded between $0.07 and $0.07, with an average price of $0.07. Over the past 52 weeks, the stock has recorded a high of $9.81 and a low of $0.07. In terms of performance, CDT Equity Inc.'s share price has declined by 97.11% over the last six months and is down 97.71% on a year-on-year basis.

CDT Equity Inc. Share Price Chart

Line chart of the CDT Equity Inc. price trend over the selected period. The price fell overall, ranging from 0.07 to 0.07, ending at 0.07.
$0.07$0.07
L
Show Current Price
H

CDT Equity Inc. Stock Fundamentals & Key Indicators

Market Cap
$2234.43
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-48.20
Revenue (TTM)
$0.00
Return On Equity (TTM)
-36.03%
Profit Margin
N/A
Debt to Equity
0.01
Quarterly Earnings Growth YoY
34.83%

CDT Equity Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$7.12-$21.33-$4.06-$4.64
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-199.58%80.97%-14.29%

CDT Equity Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$0.54-$17.80-$39.22
Net Profit MarginN/AN/AN/A
Income ChangeN/A-3196.30%-120.34%

About CDT Equity Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

CDT Equity Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.32
$0.07
-95.06%
Sep 2026
$1.51
$1.35
-28.12%
Aug 2026
$2.92
$1.89
-35.88%
Jul 2026
$0.55
$2.94
+413.09%
Jun 2026
$0.91
$0.57
-45.94%
May 2026
$2.23
$1.06
-54.41%
Apr 2026
$5.03
$2.33
-60.02%
Mar 2026
$0.65
$5.82
+752.64%
Feb 2026
$1.10
$0.68
-37.43%
Jan 2026
$1.32
$1.09
-15.50%
Dec 2025
$1.71
$1.29
-35.79%
Nov 2025
$2.69
$2.01
-31.43%

CDT Share Price FAQs